Doxorubicin Hydrochloride/Sodium Hyaluronate

็›้…ธๅคšๆŸ”ๆฏ”ๆ˜Ÿ/้€ๆ˜Ž่ดจ้…ธ้’ 

Report date: 2022/09/19 14:16:46

Base Information

Drug NameDoxorubicin Hydrochloride/Sodium Hyaluronate
Drug Alias Name้€ๆ˜Ž่ดจ้…ธ/็›้…ธๅคšๆŸ”ๆฏ”ๆ˜Ÿdoxorubicin/hyaluronic acid้€ๆ˜Ž่ดจ้…ธ้’ /็›้…ธๅคšๆŸ”ๆฏ”ๆ˜ŸHyaluronic Acid/Doxorubicin HydrochlorideDoxorubicin Hydrochloride/Hyaluronate Sodium +[7]ย 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Anthracycline antibiotics
Mechanisms of ActionDNA intercalatorsTopoisomerase II inhibitorsHyaluronic acid replacements
TargetsTopoisomerase IIDNAHyaluronic acid
Therapy Area/IndicationsNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Sodium HyaluronateDoxorubicin Hydrochloride
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlchemia Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAlchemia Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasm Metastasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A